A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip

NCT04592692 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A With Inhibitor

Interventions

DRUG: PEGylated Liposome (PEGLip)

Sponsor

Ascension Healthcare Development Limited